umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
DNA methylation signatures in precursor lymphoid neoplasms: with focus on clinical implications &  the biology behind
Umeå universitet, Medicinska fakulteten, Institutionen för medicinsk biovetenskap, Patologi.ORCID-id: 0000-0002-0759-3932
2019 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Precursor lymphoid neoplasms, namely acute lymphoblastic leukemias (ALL) and lymphoblastic lymphomas (LBL), are characterized by an aggressive proliferation of malignant progenitor B- or T-cells. To improve risk classification at diagnosis, better prognostic and treatment stratifying biomarkers are needed. Altered DNA methylation pattern is a hallmark of neoplastic transformation, and has been employed as a molecular prognostic and predictive marker in various cancers, including hematological malignancies. Our research group previously identified a CpG island methylator phenotype (CIMP) panel that classified pediatric T-ALL patients into prognostic subgroups.

The aim of this thesis was to evaluate distinct DNA methylation signatures in precursor lymphoid neoplasms, and to validate the prognostic value of CIMP classification in separate patient cohorts. Additionally, the biological mechanisms underlying the distinct CIMP methylation signatures in these malignancies were investigated.

The prognostic relevance of CIMP classification was validated in an independent Nordic cohort of pediatric T-ALL patients. Combination of CIMP status with minimal residual disease (MRD) status, could further dissect the high-risk MRD positive T-ALL patients into two CIMP subgroups with significantly distinct outcomes. Furthermore, CIMP classification at diagnosis was shown to predict overall survival in relapsed BCP-ALL patients. CIMP methylation signatures were also identified in T-LBL patients, indicating a broader relevance of CIMP based classification in lymphoid malignancies. Investigating the biology behind CIMP methylation signatures showed the association of CIMP status with the proliferative history of the leukemic cells. A differential transcriptomic analysis revealed a correlation of CIMP subgroups with known T-ALL drivers, as well as with novel genes in T-ALL biology. Finally, we identified distinct DNA methylation patterns and genetic aberrations in T-ALL and T-LBL that might contribute to the different clinical presentation of these two diseases. In conclusion, we validated the prognostic significance of CIMP methylation signature in precursor lymphoid malignancies and identified transcriptomic profiles that associated with the subgroups. DNA methylation is a strong candidate for further risk classification in lymphoid neoplasms and our findings can contribute to the identification of new potential targets for treatment.

Ort, förlag, år, upplaga, sidor
Umeå: Umeå University , 2019. , s. 82
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 2015
Nyckelord [en]
Acute Lymphoblastic Leukemia, Lymphoma, T-ALL, BCP-ALL, T-LBL, DNA methylation, CIMP, Prognosis, TAL1, HOX.
Nationell ämneskategori
Cancer och onkologi Hematologi Pediatrik Biokemi och molekylärbiologi Genetik
Identifikatorer
URN: urn:nbn:se:umu:diva-156642ISBN: 978-91-7855-023-4 (tryckt)OAI: oai:DiVA.org:umu-156642DiVA, id: diva2:1290379
Disputation
2019-03-15, Hörsal Betula, Norrlands universitetssjukhus, 90185, Umeå, 09:00 (Engelska)
Opponent
Handledare
Tillgänglig från: 2019-02-22 Skapad: 2019-02-20 Senast uppdaterad: 2019-03-14Bibliografiskt granskad
Delarbeten
1. DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia
Öppna denna publikation i ny flik eller fönster >>DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia
Visa övriga...
2016 (Engelska)Ingår i: Pediatric Blood & Cancer, ISSN 1545-5009, E-ISSN 1545-5017, Vol. 63, nr 7, s. 1185-1192Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background. Despite increased knowledge about genetic aberrations in pediatric T-cell acute lymphoblastic leukemia (T-ALL), no clinically feasible treatment-stratifying marker exists at diagnosis. Instead patients are enrolled in intensive induction therapies with substantial side effects. In modern protocols, therapy response is monitored by minimal residual disease (MRD) analysis and used for postinduction risk group stratification. DNA methylation profiling is a candidate for subtype discrimination at diagnosis and we investigated its role as a prognostic marker in pediatric T-ALL. Procedure. Sixty-five diagnostic T-ALL samples from Nordic pediatric patients treated according to the Nordic Society of Pediatric Hematology and Oncology ALL 2008 (NOPHO ALL 2008) protocol were analyzed by HumMeth450K genome wide DNA methylation arrays. Methylation status was analyzed in relation to clinical data and early T-cell precursor (ETP) phenotype. Results. Two distinct CpG island methylator phenotype (CIMP) groups were identified. Patients with a CIMP-negative profile had an inferior response to treatment compared to CIMP-positive patients (3-year cumulative incidence of relapse (CIR3y) rate: 29% vs. 6%, P = 0.01). Most importantly, CIMP classification at diagnosis allowed subgrouping of high-risk T-ALL patients (MRD >= 0.1% at day 29) into two groups with significant differences in outcome (CIR3y rates: CIMP negative 50% vs. CIMP positive 12%; P = 0.02). These groups did not differ regarding ETP phenotype, but the CIMP-negative group was younger (P = 0.02) and had higher white blood cell count at diagnosis (P = 0.004) compared with the CIMP-positive group. Conclusions. CIMP classification at diagnosis in combination with MRD during induction therapy is a strong candidate for further risk classification and could confer important information in treatment decision making.

Nyckelord
childhood leukemia, DNA methylation, MRD, prognosis, T-ALL, WBC
Nationell ämneskategori
Cancer och onkologi Hematologi Pediatrik
Identifikatorer
urn:nbn:se:umu:diva-124837 (URN)10.1002/pbc.25958 (DOI)000380105400008 ()26928953 (PubMedID)
Tillgänglig från: 2016-10-03 Skapad: 2016-08-26 Senast uppdaterad: 2019-05-10Bibliografiskt granskad
2. DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Öppna denna publikation i ny flik eller fönster >>DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Visa övriga...
2018 (Engelska)Ingår i: Clinical Epigenetics, E-ISSN 1868-7083, Vol. 10, artikel-id 31Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background: Few biological markers are associated with survival after relapse of B-cell precursor acute lymphoblastic leukemia (BCP-ALL). In pediatric T-cell ALL, we have identified promoter-associated methylation alterations that correlate with prognosis. Here, the prognostic relevance of CpG island methylation phenotype (CIMP) classification was investigated in pediatric BCP-ALL patients.

Methods: Six hundred and one BCP-ALL samples from Nordic pediatric patients (age 1-18) were CIMP classified at initial diagnosis and analyzed in relation to clinical data.

Results: Among the 137 patients that later relapsed, patients with a CIMP-profile (n = 42) at initial diagnosis had an inferior overall survival (pOS(5years) 33%) compared to CIMP+ patients (n = 95, pOS(5years) 65%) (p = 0.001), which remained significant in a Cox proportional hazards model including previously defined risk factors.

Conclusion: CIMP classification is a strong candidate for improved risk stratification of relapsed BCP-ALL.

Ort, förlag, år, upplaga, sidor
BioMed Central, 2018
Nyckelord
DNA methylation, BCP-ALL, prognosis, CIMP, relapse, risk stratification
Nationell ämneskategori
Hematologi
Identifikatorer
urn:nbn:se:umu:diva-146216 (URN)10.1186/s13148-018-0466-3 (DOI)000427080200001 ()29515676 (PubMedID)
Tillgänglig från: 2018-05-08 Skapad: 2018-05-08 Senast uppdaterad: 2019-02-20Bibliografiskt granskad
3. An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression
Öppna denna publikation i ny flik eller fönster >>An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression
Visa övriga...
2019 (Engelska)Ingår i: Cancer Medicine, ISSN 2045-7634, E-ISSN 2045-7634, Vol. 8, nr 1, s. 311-324Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Classification of pediatric T‐cell acute lymphoblastic leukemia (T‐ALL) patients into CIMP (CpG Island Methylator Phenotype) subgroups has the potential to improve current risk stratification. To investigate the biology behind these CIMP subgroups, diagnostic samples from Nordic pediatric T‐ALL patients were characterized by genome‐wide methylation arrays, followed by targeted exome sequencing, telomere length measurement, and RNA sequencing. The CIMP subgroups did not correlate significantly with variations in epigenetic regulators. However, the CIMP+ subgroup, associated with better prognosis, showed indicators of longer replicative history, including shorter telomere length (P = 0.015) and older epigenetic (P < 0.001) and mitotic age (P < 0.001). Moreover, the CIMP+ subgroup had significantly higher expression of ANTP homeobox oncogenes, namely TLX3, HOXA9, HOXA10, and NKX2‐1, and novel genes in T‐ALL biology including PLCB4, PLXND1, and MYO18B. The CIMP− subgroup, with worse prognosis, was associated with higher expression of TAL1 along with frequent STIL‐TAL1 fusions (2/40 in CIMP+ vs 11/24 in CIMP−), as well as stronger expression of BEX1. Altogether, our findings suggest different routes for leukemogenic transformation in the T‐ALL CIMP subgroups, indicated by different replicative histories and distinct methylomic and transcriptomic profiles. These novel findings can lead to new therapeutic strategies.

Ort, förlag, år, upplaga, sidor
John Wiley & Sons, 2019
Nyckelord
BEX1, DNA methylation, HOXA, pediatric acute lymphoblastic leukemia, TAL1
Nationell ämneskategori
Cancer och onkologi Hematologi Pediatrik Biokemi och molekylärbiologi
Identifikatorer
urn:nbn:se:umu:diva-156637 (URN)10.1002/cam4.1917 (DOI)000456858100032 ()30575306 (PubMedID)
Forskningsfinansiär
KempestiftelsernaBarncancerfondenVästerbottens läns landstingVetenskapsrådetKnut och Alice Wallenbergs Stiftelse
Tillgänglig från: 2019-02-20 Skapad: 2019-02-20 Senast uppdaterad: 2020-04-08Bibliografiskt granskad
4. Epigenetic and genetic distinctions between T-cell acute lymphoblastic leukemia and lymphoma
Öppna denna publikation i ny flik eller fönster >>Epigenetic and genetic distinctions between T-cell acute lymphoblastic leukemia and lymphoma
Visa övriga...
(Engelska)Manuskript (preprint) (Övrigt vetenskapligt)
Nationell ämneskategori
Cancer och onkologi Hematologi Pediatrik Genetik
Identifikatorer
urn:nbn:se:umu:diva-156641 (URN)
Tillgänglig från: 2019-02-20 Skapad: 2019-02-20 Senast uppdaterad: 2019-02-21

Open Access i DiVA

fulltext(3631 kB)65 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 3631 kBChecksumma SHA-512
b9146575e3cc965835b13218ff2ff53d54526d2372ca7e42120a0b04f5ec6026a69c07e5cec7682c047c6a39536e488220b4345b95558520a0a3af8d48939dbc
Typ fulltextMimetyp application/pdf
spikblad(141 kB)10 nedladdningar
Filinformation
Filnamn FULLTEXT02.pdfFilstorlek 141 kBChecksumma SHA-512
ad946a94bd8e2210df526a71ebfde567522c1df58f159f6b061b65a4136de9ce274fa43f9681f4e7a6c6d51dae97ac50beb8ea268834eb59a5100eea185ac7b7
Typ spikbladMimetyp application/pdf

Personposter BETA

Haider, Zahra

Sök vidare i DiVA

Av författaren/redaktören
Haider, Zahra
Av organisationen
Patologi
Cancer och onkologiHematologiPediatrikBiokemi och molekylärbiologiGenetik

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 75 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

isbn
urn-nbn

Altmetricpoäng

isbn
urn-nbn
Totalt: 1071 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf